Rina Agustina

Dr. Rina Agustina


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in The Lancet
Verified
Journal Article
Closed access
WWWalter Willett
Walter Willett
JRJohan Rockström
Johan Rockström
BLBrent Loken
Brent Loken
MSMarco Springmann
Marco Springmann
TLTim Lang
Tim Lang
CMChristopher J L Murray
Christopher J L Murray

1 January 2019 in The Lancet
Verified
Journal Article
Closed access
RARina Agustina
Rina Agustina
TDTeguh Dartanto
Teguh Dartanto
RSRatna Sitompul
Ratna Sitompul
KSKun Aristiati Susiloretni
Kun Aristiati Susiloretni
EAEndang L Achadi
Endang L Achadi
IGIndonesian Health Systems Group
Indonesian Health Systems Group

1 November 2017 in The Lancet Global Health
Verified
Journal Article
Open access
ESEmily R Smith
Emily R Smith
ASAnuraj H Shankar
Anuraj H Shankar
LWLee S-F Wu
Lee S-F Wu
SASaid Aboud
Said Aboud
SASeth Adu-Afarwuah
Seth Adu-Afarwuah
CSChristopher Sudfeld
Christopher Sudfeld
Micronutrient deficiencies are common among women in low-income and middle-income countries. Data from randomised trials suggest that maternal multiple micronutrient supplementation decreases the risk of low birthweight and potentially improves other infant health outcomes. However, heterogeneity across studies suggests influence from effect modifiers. We aimed to identify individual-level modifiers of the effect of multiple micronutrient supplements on stillbirth, birth outcomes, and infant mortality in low-income and middle-income countries. This two-stage meta-analysis of individual patient included data from 17 randomised controlled trials done in 14 low-income and middle-income countries, which compared multiple micronutrient supplements containing iron-folic acid versus iron-folic acid alone in 112 953 pregnant women. We generated study-specific estimates and pooled subgroup estimates using fixed-effects models and assessed heterogeneity between subgroups with the χ2 test for heterogeneity. We did sensitivity analyses using random-effects models, stratifying by iron-folic acid dose, and exploring individual study effect. Multiple micronutrient supplements containing iron-folic acid provided significantly greater reductions in neonatal mortality for female neonates compared with male neonates than did iron-folic acid supplementation alone (RR 0·85, 95% CI 0·75-0·96 vs 1·06, 0·95-1·17; p value for interaction 0·007). Multiple micronutrient supplements resulted in greater reductions in low birthweight (RR 0·81, 95% CI 0·74-0·89; p value for interaction 0·049), small-for-gestational-age births (0·92, 0·87-0·97; p=0·03), and 6-month mortality (0·71, 0·60-0·86; p=0·04) in anaemic pregnant women (haemoglobin <110g/L) as compared with non-anaemic pregnant women. Multiple micronutrient supplements also had a greater effect on preterm births among underweight pregnant women (BMI <18·5 kg/m2; RR 0·84, 95% CI 0·78-0·91; p=0·01). Initiation of multiple micronutrient supplements before 20 weeks gestation provided greater reductions in preterm birth (RR 0·89, 95% CI 0·85-0·93; p=0·03). Generally, the survival and birth outcome effects of multiple micronutrient supplementation were greater with high adherence (≥95%) to supplementation. Multiple micronutrient supplements did not significantly increase the risk of stillbirth or neonatal, 6-month, or infant mortality, neither overall or in any of the 26 examined subgroups. Antenatal multiple micronutrient supplements improved survival for female neonates and provided greater birth-outcome benefits for infants born to undernourished and anaemic pregnant women. Early initiation in pregnancy and high adherence to multiple micronutrient supplements also provided greater overall benefits. Studies should now aim to elucidate the mechanisms accounting for differences in the effect of antenatal multiple micronutrient supplements on infant health by maternal nutrition status and sex. None.

19 October 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
RARina Agustina
Rina Agustina
TSTirta P Sari
Tirta P Sari
SSSoemilah Satroamidjojo
Soemilah Satroamidjojo
IBIngeborg Mj Bovee-Oudenhoven
Ingeborg Mj Bovee-Oudenhoven
EFEdith Feskens
Edith Feskens
FKFrans J Kok
Frans J Kok
Information on the part that poor food-hygiene practices play a role in the development of diarrhea in low socioeconomic urban communities is lacking. This study was therefore aimed at assessing the contribution of food-hygiene practice to the prevalence of diarrhea among Indonesian children.

7 March 2007 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
TGTim Green
Tim Green
CSC M Skeaff
C M Skeaff
JRJ E P Rockell
J E P Rockell
BVB J Venn
B J Venn
ALA Lambert
A Lambert
SWS J Whiting
S J Whiting

1 May 2012 in Pediatrics
Verified
Journal Article
Closed access
PDF file
RARina Agustina
Rina Agustina
FKFrans J. Kok
Frans J. Kok
OROndine van de Rest
Ondine van de Rest
UFUmi Fahmida
Umi Fahmida
AFAgus Firmansyah
Agus Firmansyah
IBIngeborg M. J. Bovee-Oudenhoven
Ingeborg M. J. Bovee-Oudenhoven
OBJECTIVE: To investigate the effects of calcium and probiotics on the incidence and duration of acute diarrhea and acute respiratory tract infections (ARTIs) in low-socioeconomic communities of Jakarta, Indonesia. METHODS: We conducted a 6-month, double-blind, placebo-controlled study in 494 healthy children aged 1 to 6 years who received low-lactose milk with low calcium content (LC; ∼50 mg/day; n = 124), regular calcium content (RC; ∼440 mg/day; n = 126), RC with 5.108 colony-forming units per day of Lactobacillus casei CRL431 (casei; n = 120), or RC with 5.108 colony-forming units per day of Lactobacillus reuteri DSM17938 (reuteri; n = 124). Number and duration of diarrhea and ARTIs episodes were primary and secondary outcomes, respectively. RESULTS: Incidence of World Health Organization–defined diarrhea (≥3 loose/liquid stools in 24 hours) was not significantly different between RC and LC (relative risk [RR]: 0.99 [95% confidence interval (CI): 0.62–1.58]), between casei and RC (RR: 1.21 [95% CI: 0.76–1.92]), or between reuteri and RC (RR: 0.76 [95% CI: 0.46–1.25]) groups. Incidence of all reported diarrhea (≥2 loose/liquid stools in 24 hours) was significantly lower in the reuteri versus RC group (RR: 0.68 [95% CI: 0.46–0.99]). Irrespective of the definition used, reuteri significantly reduced diarrhea incidence in children with lower nutritional status (below-median height-and-weight-for-age z score). None of the interventions affected ARTIs. CONCLUSIONS: RC milk, alone or with L casei, did not reduce diarrhea or ARTIs in Indonesian children. L reuteri may prevent diarrhea, especially in children with lower nutritional status.